San Francisco Sentry Investment Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$6K Hold
106
﹤0.01% 557
2021
Q1
$6K Hold
106
﹤0.01% 590
2020
Q4
$5K Sell
106
-114
-52% -$4.94K ﹤0.01% 564
2020
Q3
$8K Hold
220
﹤0.01% 499
2020
Q2
$8K Sell
220
-96
-30% -$3.34K ﹤0.01% 503
2020
Q1
$9K Sell
316
-1,970
-86% -$87.4K 0.01% 492
2019
Q4
$117K Buy
2,286
+490
+27% +$23.7K 0.05% 272
2019
Q3
$85K Sell
1,796
-2
-0.1% -$95 0.04% 298
2019
Q2
$89K Buy
1,798
+1,083
+151% +$50.9K 0.04% 300
2019
Q1
$30K Sell
715
-718
-50% -$31.7K 0.01% 449
2018
Q4
$59K Buy
1,433
+263
+22% +$11.3K 0.03% 354
2018
Q3
$55K Sell
1,170
-17
-1% -$777 0.02% 385
2018
Q2
$52K Sell
1,187
-7
-0.6% -$326 0.02% 382
2018
Q1
$55K Buy
1,194
+293
+33% +$14.2K 0.02% 446
2017
Q4
$46K Sell
901
-60
-6% -$3.16K 0.01% 462
2017
Q3
$50K Buy
961
+842
+708% +$41K 0.02% 433
2017
Q2
$6K Buy
+119
New +$5.52K ﹤0.01% 584

Other funds holding MET

San Francisco Sentry Investment Group's MET Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its MetLife (MET) position steady in Q2 2021 at 106 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #557.

San Francisco Sentry Investment Group first reported a position in MET in Q2 2017 and has held it in 17 quarters since. The position peaked at $117K in Q4 2019. 1,120 funds tracked by Wall St. Rank hold MET as of Q2 2021.

  • San Francisco Sentry Investment Group held 106 shares of MetLife worth $6K as of Q2 2021.
  • San Francisco Sentry Investment Group left its MetLife share count unchanged in Q2 2021.
  • MetLife made up ﹤0.01% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #557 holding.
  • San Francisco Sentry Investment Group first reported a position in MetLife in Q2 2017 and has held it in 17 quarters since.
  • San Francisco Sentry Investment Group's MetLife position peaked at $117K in Q4 2019.
  • 1,120 funds tracked by Wall St. Rank held MetLife as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.